111 related articles for article (PubMed ID: 20162752)
21. Warning: bisphosphonates and osteochemonecrosis of the jaws.
Flint SR; Sharkey S; Galvin S
J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369
[TBL] [Abstract][Full Text] [Related]
22. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Aragon-Ching JB; Dahut WL
Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
[No Abstract] [Full Text] [Related]
23. Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.
Landis BN; Richter M; Dojcinovic I; Hugentobler M
BMJ; 2006 Nov; 333(7576):982-3. PubMed ID: 17095762
[No Abstract] [Full Text] [Related]
24. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
Geist RY; Geist JR; Aksu M
J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
[No Abstract] [Full Text] [Related]
25. Osteonecrosis: what dentists need to know.
Thoman RD
Hawaii Dent J; 2006; 37(6):9-10, 12-3. PubMed ID: 17290948
[No Abstract] [Full Text] [Related]
26. Oral bisphosphonates and osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
[No Abstract] [Full Text] [Related]
27. Bisphosphonate treatment as a cause of jaw osteonecrosis.
Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
[No Abstract] [Full Text] [Related]
28. Bisphosphonate associated osteonecrosis of the jaw; similarities and differences in oncologic and non-oncologic patients.
Chogle AR
J Assoc Physicians India; 2011 Aug; 59():477-8. PubMed ID: 21887901
[No Abstract] [Full Text] [Related]
29. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
[No Abstract] [Full Text] [Related]
30. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
[TBL] [Abstract][Full Text] [Related]
31. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
Assael LA
J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488
[No Abstract] [Full Text] [Related]
32. The tip of the iceberg.
Felsenfeld AL
J Calif Dent Assoc; 2005 Oct; 33(10):765-6. PubMed ID: 16350878
[No Abstract] [Full Text] [Related]
33. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
Jimenez-Soriano Y; Bagan JV
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
[No Abstract] [Full Text] [Related]
34. [Bisphosphonates].
van Nuijs T
Rev Belge Med Dent (1984); 2007; 62(4):151. PubMed ID: 18506989
[No Abstract] [Full Text] [Related]
35. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
Kyrgidis A; Vahtsevanos K
J Craniomaxillofac Surg; 2011 Jun; 39(4):271. PubMed ID: 20434920
[No Abstract] [Full Text] [Related]
36. The bisphosphonates struggle.
Johnston JW
J Mich Dent Assoc; 2006 Oct; 88(10):12. PubMed ID: 17078336
[No Abstract] [Full Text] [Related]
37. Treating osteoporosis.
Smith G; Stassen L; Flint S
Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
[No Abstract] [Full Text] [Related]
38. Bisphosphonate-related osteonecrosis of the jaw: an overview.
Ruggiero SL
Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
[TBL] [Abstract][Full Text] [Related]
39. Low-down on link between bone-builders and jaw damage.
Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363
[No Abstract] [Full Text] [Related]
40. Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.
McMahon RE; Bouquot JE; Glueck CJ; Griep J
J Oral Maxillofac Surg; 2006 Nov; 64(11):1704-5. PubMed ID: 17052602
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
